A Review of Clinical Trials Assessing the Efficacy and Safety of Newer Antiarrhythmic Drugs in Atrial Fibrillation

Author： Naccarelli G.V. Wolbrette D.L. Bhatta L. Khan M. Hynes J. Samii S. Luck J.

ISSN： 1383-875X

Source： Journal of Interventional Cardiac Electrophysiology, Vol.9, Iss.2, 2003-10, pp. : 215-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trials of New Antiarrhythmic Drugs for Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation: Current Topics in the Management of Atrial Fibrillation

By Singh Steven

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 1, 2004-02 ,pp. : 71-76

Springer Publishing Company

Access to resources Recommend Favorite

Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management

Current Vascular Pharmacology, Vol. 5, Iss. 3, 2007-07 ,pp. : 185-194

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter

By Hauser T.H. Pinto D.S. Josephson M.E. Zimetbaum P.

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 68-68

Elsevier

Access to resources Recommend Favorite

Vernakalant (RSD1235) in the management of atrial fibrillation: a review of pharmacological properties, clinical efficacy and safety

By Weeke Peter Andersson Charlotte Brendorp Bente Torp-Pedersen Christian

Future Cardiology, Vol. 4, Iss. 6, 2008-11 ,pp. : 559-567

Future Medicine

Access to resources Recommend Favorite

Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs: Update on Clinical Trial Results

By Sung R.J.

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 300-303

Springer Publishing Company

Access to resources Recommend Favorite